Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

TDAC vs HCAC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TDAC Wins Head-to-Head Institutional Verdict (3–0 across 6 Pillars · 6–3 Matrix Metrics)

TDAC Overall Winner 6-Pillar Tally: TDAC 3 – 0 HCAC (3 Tie) Matrix Metrics: TDAC 6 – 3 HCAC

As of Nov 16, 2026, Translational Development Acquisition Corp. (TDAC) is the stronger overall head-to-head candidate over HCAC (HCAC) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TDAC carries a Unified Composite Score of 55.4/100 (HOLD) at $10.86 (N/M Forward P/E, 0.0% operating margin), whereas HCAC carries 57.2/100 (HOLD) at $10.26 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While HCAC currently prints a higher short-term Unified Composite Score (57.2/100 HOLD vs. TDAC 55.4/100 HOLD), TDAC captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–0 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TDAC vs HCAC
TDAC NASDAQ Head-to-Head Winner
Translational Development Acquisition Corp. Ordinary Shares
Blank Checks
$10.86
-0.18% 1D
Market Cap $210.1M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.04β · 3% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 47.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 55
RSI-14: 55.2 · SMA20: $10.85 · SMA50: $10.85
HCAC US Equity
HCAC
Institutional Equity
$10.26
+0.2% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 2% Vol
Unified Composite Score
57.2 / 100 HOLD
Tech 58.0 Fund 50.0 Flow 50.0 Mom 36.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 81
RSI-14: 80.8 · SMA20: $10.16 · SMA50: $10.13

6-Pillar Scorecard Institutional Category Breakdown (TDAC 3 – 0 HCAC)

Columns: Metric · TDAC · HCAC
1. Valuation Multiples TDAC
Forward P/E N/M N/M
Trailing P/E 41.9x N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale TDAC
Revenue Growth (YoY) +0.0% N/A
Earnings Growth (YoY) -40.6% N/A
TTM Revenue (USD) N/A N/A
Market Cap $210.1M N/A
3. Profitability & Quality TDAC
Gross Margin N/A N/A
Operating Margin 0.0% N/A
Net Profit Margin 0.0% N/A
Return on Equity (ROE) 0.0% N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TDAC (6) vs HCAC (3)
Institutional Metric TDAC HCAC Criterion Row Edge
Market Capitalization
Scale
$210.1M N/A Larger Scale TDAC
Trailing P/E Ratio
Valuation
41.9x N/M Lower Multiple TDAC
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% N/A Higher Growth TDAC
Operating Margin (TTM)
Profitability
0.0% N/A Higher Margin TDAC
Net Profit Margin
Profitability
0.0% N/A Higher Margin TDAC
Return on Equity (ROE)
Capital Efficiency
0.0% N/A Higher ROE TDAC
52-Week Range Position
Momentum
86% ($10–$11) 100% ($10–$10) Stronger Trend HCAC
Beta / 30D Volatility
Risk Regime
0.04β · 3% Vol 0.02β · 2% Vol Lower Realized Risk HCAC
Unified Institutional Score
Composite Signal
55.4 / 100 (HOLD) 57.2 / 100 (HOLD) Higher Composite HCAC
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HCAC +0.94 pp
TDAC: +0.14% · HCAC: +1.08%
3M Horizon HCAC +1.61 pp
TDAC: +0.28% · HCAC: +1.89%
6M Horizon HCAC +0.49 pp
TDAC: +2.94% · HCAC: +3.43%
1Y Horizon TDAC +1.04 pp
TDAC: +3.13% · HCAC: +2.09%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TDAC vs HCAC. Trailing 12-month operating profitability (TDAC 0.0% vs HCAC N/A) and valuation multiples (TDAC N/M vs HCAC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

TDAC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
HCAC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TDAC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TDAC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HCAC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HCAC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TDAC Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $210.1M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HCAC Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ TDAC vs HCAC Key Questions & Quantitative Answers

As of Nov 16, 2026, Translational Development Acquisition Corp. (TDAC) is the stronger overall head-to-head candidate over HCAC (HCAC) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TDAC carries a Unified Composite Score of 55.4/100 (HOLD) at $10.86 (N/M Forward P/E, 0.0% operating margin), whereas HCAC carries 57.2/100 (HOLD) at $10.26 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While HCAC currently prints a higher short-term Unified Composite Score (57.2/100 HOLD vs. TDAC 55.4/100 HOLD), TDAC captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–0 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).

TDAC leads the Growth & Scale pillar: TDAC posts +0.0% YoY revenue growth and -40.6% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with HCAC at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, TDAC generates N/A in USD-normalized revenue versus N/A for HCAC. In operating R&D and SG&A reinvestment, TDAC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HCAC.

TDAC screens cheaper on headline valuation multiples. TDAC trades at N/M Forward P/E, 41.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HCAC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TDAC (0.0% ROE) versus HCAC (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, TDAC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 3% Vol realized risk). By comparison, HCAC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.